EMBL Australia

The 2025 Australian and European Health Research Infrastructure Symposium brought together Australian and international research infrastructure (RI) communities from health and the life sciences to strengthen international partnerships and tackle shared challenges.

EMBL Australia is pleased to announce the expansion of its Partner Laboratory Network Steering Committee, welcoming new senior representatives from leading research institutions across the country.

Professor Peter Currie, Director of Research at the Australian Regenerative Medicine Institute (ARMI) at Monash University and EMBL Australia ARMI Institutional Representative, has been elected as an Associate Member of the European Molecular Biology Organization (EMBO), in recognition of his scientific achievements in regenerative biology.

EMBL Australia group leader Dr William Roman & his team have launched a new imaging-based spatial transcriptomics platform that dramatically reduces experimental costs from more than $35,000 to approximately $30 per experiment, making spatial biology more accessible to researchers across Australia.

News this quarter:

• Prof Jose Polo appointed as EMBL Australia Scientific Head
• Measuring what matters: the EMBL Australia Impact Report
• Collaborative approach to AI at EMBL Partnership Conference
• Advancing bioimaging through collaboration and innovation
• EMBL Australia PhD Course applications opening soon
• EMBL’s plan to leverage the full potential of AI technologies
• Antibiotics hinder vaccine responses in infants
• Get to know… Ricki Mailloux (Project Officer)

And more:

• Job opportunities
• Upcoming events
• Access to EMBL
• Recent publications

EMBL Australia Group Leader Dr Senthil Arumugam has co-launched the Monash BDI Advanced Bioimaging (MAB) platform – a researcher-led, global collaboration hub designed to bring innovative microscopy technologies directly to the researchers who need them.

For more than 15 years, EMBL Australia has focused on attracting the very best emerging scientists from across the globe to Australia and delivering top-quality science, as well as state-of-the-art interdisciplinary training to the next generation of researchers. The return on investment is evident.

Looking ahead, sustained long-term investment into international partnerships is essential for Australia to remain at the forefront of health and science research.

In addition to translating discoveries to improve patients’ lives, our group leaders develop transformative tools for the scientific community. One such innovation is a freely available, ultracompact and highly sensitive 3D-printed microscope with the potential to revolutionise health diagnostics.

EMBL Australia group leaders are deeply integrated into Australian and international networks of excellence. They have established themselves as scientists and drive research and innovation in areas of national scientific priority.